Rejuran in Daegu: which skin does it suit, and which not?
“I heard Rejuran makes your skin better.” We hear this often at consultation. It isn’t wrong, but something is missing. What Rejuran improves is the state of the dermis — texture · pores · hydration; hollow cheeks or sagging are a different story. This piece separates skin that is a candidate for Rejuran from skin that isn’t, and sets out what human trials actually showed.
The short answer
Rejuran is a skin booster that puts polynucleotide (PN) purified from salmon · trout into the dermis to change the recovery environment; candidates are thinned, rough skin and skin with sagging pores. In a 27-person split-face trial, improvement rates for roughness · pore volume · elasticity · hydration were higher than on the hyaluronic acid side, but subjective cosmetic scales did not differ (Lee 2022), and it is not an answer for a face with lost volume or a sagging contour. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) designs Rejuran as a course of 3–4 sessions 3–4 weeks apart, and if volume · sagging is the main concern, tells you about another direction first (clinical judgement).
What does Rejuran inject?
Rejuran’s main ingredient is polynucleotide (PN). It is a long-chain polymer extracted and purified from salmon · trout, and an aqueous injection that is liquid from the start. It is not particulate, so it isn’t a structure that clumps into granules, and it acts while gradually breaking down in the body.
| Formulation | Composition | Considered when |
|---|---|---|
| Healer | PN alone | Texture · dermal density as the main goal |
| HB | PN + hyaluronic acid | When less swelling after treatment is needed |
| HB PLUS | PN + hyaluronic acid + lidocaine | When worried about pain, or treating a broad area |
We couldn’t confirm a trial comparing the three formulations under the same conditions. The table shows conditions, not ranking. Each formulation is covered in Rejuran Healer · HB · HB PLUS · Eye: the differences.
Which skin is a candidate for Rejuran?
| Skin condition | Judgement | Reason |
|---|---|---|
| Thinned and rough, with sagging pores | Candidate | The axis on which improvement rates for roughness · pore volume were higher in a 27-person trial |
| Fine lines · dryness around the eyes | Candidate | The area covered by the key trial was around the eyes |
| Sensitive skin that often flushes | Conditional | A degradable material, so the burden of starting is relatively low. No data directly comparing it with other categories |
| First-ever booster | Candidate | When you don’t yet want to put in an irreversible material |
| Hollow cheeks · sagging facial contour | Not a candidate | Its mechanism is not filling or lifting |
Even with sensitive skin, if flushing is severe at the time, we calm it first and then start. Injection is also a stimulus, and it becomes hard to tell treatment reactions from existing redness (clinical judgement).
Which faces does Rejuran not suit?
A face where hollow cheeks cast shadows or a face with a blurred jawline is not where Rejuran belongs. Even after completing all the sessions, the change you wanted is quite likely not to come.
- If volume is lost — it’s for filling materials. See the ‘hollowing · volume’ branch of the skin-booster map.
- If the facial contour sags — it’s for RF lifting. Criteria are separated in Booster or lifting?.
- If brown · red colour is the concern — it’s the domain of lasers. Miso Clinic has no melasma laser.
- If PCL · PLLA · CaHA recently went into the same area — telling causes apart is hard, so we adjust the timing.
What did human trials show?
The key trial is a 27-person randomised · double-blind · split-face trial of the eye area. PN on one side and hyaluronic acid on the other were injected three times 2 weeks apart. Subjective cosmetic scales (VAS · GAIS) didn’t differ between sides, while improvement rates for roughness · pore volume · elasticity · hydration were higher on the PN side. Dermal density did not differ (Lee 2022).
Other data point the same way. A 30-person study comparing with PCL showed no difference on the wrinkle scale at 12 weeks (Jeong 2020), and a systematic review of 9 PN studies with 219 people rated the quality of evidence “low to moderate” (Lampridou 2025).
How to read it — it is accurate to read it not as “pores disappear” but as “indicators on the side of refined texture moved.” Samples are small and the key trial followed up for 12 weeks, so lasting a year is an estimate, not a measured value.
How do embossing and pain differ?
The plump rise at the injection points after Rejuran (embossing · papules) is swelling from the drug pooling in the dermis. It is a different phenomenon from the nodules of particle products, and usually settles in 1–2 days.
There were differences by formulation design. In a 15-person trial, pain VAS split 3.39 vs 5.04 and embossing 13.3% vs 56.7%. But wrinkle · global improvement scales did not differ (Jeon 2025). So if you have an important event within 2–3 days, adjusting the date is better.
The course is in Rejuran papules: cause and course, and pain in Rejuran: does it hurt · how is numbing done?.
How many sessions, at what interval?
- Same dayEmbossing · rednessYour face that day is not the result
- 1–2 daysUsually settlesBack to daily life
- 3–4 weeks laterNext sessionMiso Clinic’s standard interval (clinical judgement)
- After 3–4 sessionsCourse endsCompare with pre-treatment photos
- After thatTop up by conditionOne session at a time when it gets dry and rough again
Miso Clinic recommends 3–4 sessions 3–4 weeks apart as one course (clinical judgement). As a degradable material, it is designed to build up rather than finish in one go. But no trial has set “X sessions is the right answer.” Sessions are covered in the Rejuran sessions guide.
When does another booster suit better?
- When the skin has thinned so much that you feel the material itself is lacking — hADM. Skin that suits Re2O
- When you want to raise whole-face density evenly — liquid PCL. Skin that suits Gouri
- When you need immediate hydration and room to reverse — crosslinked hyaluronic acid (BYRYZN)
- When the name PN gets confused with PDRN — The difference between PN and PDRN
We couldn’t confirm a trial directly comparing PN with hADM · liquid PCL in the same people. So you can choose by target rather than ranking.
Which skin suits Rejuran in Daegu: frequently asked questions
Which skin does Rejuran suit?
Candidates are thinned, rough skin, skin with sagging pores, and fine lines and dryness around the eyes. In a 27-person split-face trial, improvement rates for roughness · pore volume · elasticity · hydration were higher than on the hyaluronic acid side.
Does Rejuran fill hollow cheeks too?
No. Rejuran is not a filling material but one that changes the dermis’s recovery environment. If volume is the main concern, we look at filling materials.
How long does Rejuran embossing last?
It usually settles in 1–2 days. In a 15-person trial, embossing split 13.3% and 56.7% depending on formulation design. If you have an event, allow 2–3 days of leeway.
How many sessions of Rejuran do I need?
Miso Clinic recommends 3–4 sessions 3–4 weeks apart as one course. But no trial has set the right number, and after the course we top up according to condition.
Does the Rejuran effect last a year?
The key trial followed up for 12 weeks, so lasting a year is an estimate, not a measured value. Miso Clinic decides the next step by skin condition rather than the calendar.
Where can I get a Rejuran consultation in Daegu?
Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.
Clinical columns to read next
Product reference
Product reference: Rejuran · Rejuran treatment guide
Clinic
This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.
| Medical Director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building |
| Phone | 053-428-2700 |
| KakaoTalk consultation | Miso Clinic Daegu channel |
| KakaoTalk channel | Add the channel |
| Opening hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Clinical column | See all columns |
| Reference library | All booster and lifting device references |
References
- Eye-area comparison trial of PN and hyaluronic acid — Lee YJ et al., J Dermatolog Treat 2022;33(1):254–260, PMID 32248707. Randomised · double-blind · split face, 27 people, three sessions 2 weeks apart. No difference between sides in subjective cosmetic scales (VAS · GAIS); improvement rates for roughness · pore volume · elasticity · hydration higher on the PN side. No difference in dermal density. (Cited from /column/daegu-rejuran-skin-fit/)
- PN formulation design and pain · embossing — Jeon W et al., Aesthetic Plast Surg 2025;50(7):2723–2730, PMID 41361144. 15 people. Pain VAS 3.39 vs 5.04, embossing 13.3% vs 56.7%, erythema 40% vs 60%. No difference in wrinkle · global improvement scales. (Cited from /column/daegu-rejuran-skin-fit/)
- PN vs PCL — Jeong GJ et al., J Cosmet Dermatol 2020;19(7):1593–1599, PMID 31680395. 30 people; no significant difference in wrinkle · global improvement scales at 12 weeks. (Cited from /column/daegu-rejuran-skin-fit/)
- Systematic review of PN — Lampridou S et al., J Cosmet Dermatol 2025;24(2):e16721, PMID 39645667. 9 studies, 219 people; evidence quality “low to moderate.” (Cited from /column/daegu-rejuran-skin-fit/)
- Rejuran HB PLUS — made by Pharma Research, PN + hyaluronic acid + lidocaine, Korean medical device. The course of 3–4 sessions 3–4 weeks apart is Miso Clinic’s recommended design.
- Level of PN evidence — Polynucleotides in Aesthetic Medicine: Current Practices and Perceived Effectiveness, Int J Mol Sci 2024 (evidence grade and limitations) · Expert Perspectives: Evidence-Based Applications of Polynucleotides, Clin Cosmet Investig Dermatol (that it is not a volumiser).
- Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
- Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.